- Exchange: OTCBB
Immureboost Inc. announced on September 5th 2008 a name change toFountain Healthy Aging Inc.
Advertisement
Fountain Healthy Aging Inc. said this approval follows the earlierapproval of the name change by the Board of Directors and the Shareholders ofthe Company.
Advertisement
CEO, Dr Tony Jimenez said a name change "was appropriate as we have a newdirection and a completely new business plan "
Dr Jimenez went on to say that; "Fountain Healthy Aging Inc. will be apioneer in the anti- aging industry with our new flagship product Vitalife.Vitalife is the world's first and only transdermal growth hormone releasinghormone (GHRH) analog. Studies show statistically significant increases inhGH levels from baseline, after treatment with Vitalife."
Currently the Anti-aging industry is a US$30 Billion market. We estimatethat this industry will grow by US$12 Billion in the next year and a halfalone, and to US$70 Billion in the next 3 years. The worldwide global antiaging market is expected to reach US$115.5 Billion by 2010, and is now one ofthe fastest growing business segments in the world.
In the next few months, Fountain Healthy Aging, will focus ontransitioning Vitalife into the mass market. Our existing clinical data willbe bolstered by 5 additional clinical trials conducted in countries aroundthe world that will provide further evidence of the product's safety andefficacy.
About Fountain Healthy Aging
Fountain Healthy Aging is a company specifically focussed in the antiaging industry, which is one of the quickest growing industry sectorsworldwide. We have a range of products targeted at the anti aging market,including our revolutionary flagship product Vitalife, which we believe isready to make a massive impact in the anti-aging industry. We recognize theimportance of the anti-aging sector, an emerging dynamic within the overallhealth and wellness revolution. We believe that we are uniquely positioned tocapitalize on this rapidly growing trend first with our unique flagshipproduct, rapidly followed into the market by our other products which havebeen specifically developed for this market. Fountain Healthy Aging's mainfocus is on the specialty, premium product category, which is a growingsegment of the market that provides gross margins significantly higher thatthe lower-priced, mainstream health products market.
The statements in the press release that relate to the company'sexpectations with regard to the future impact on the company's results fromnew products or actions in development are forward-looking statements, withinthe meaning of the Private Securities Litigation Reform Act of 1995. Thestatements in this document may also contain "forward-looking statements"within the meaning of Section 27A of the Securities Act of 1933 and Section21E of the Securities Exchange Act of 1934. Since this information maycontain statements that involve risk and uncertainties and are subject tochange at any time, the company's actual results may differ materially fromexpected results.For more information please contact: Blue Chip IR, Investor Relations [email protected] +1-604-392-2583
SOURCE Fountain Healthy Aging Inc
